+21.6%
CGNX vs BBIO
+18.4%
+3.2%
-34.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.6% | 0.0% | +0.6% | +0.6% |
| 7D | -14.9% | -0.9% | -14.0% | -14.7% |
| 30D | -21.9% | +11.7% | -33.7% | -24.2% |
| 3M | -29.0% | -10.3% | -18.7% | -26.9% |
| 6M | -23.0% | +9.1% | -32.2% | -26.6% |
| YTD | +33.4% | -2.9% | +36.2% | +31.3% |
| 1Y | +21.6% | +18.4% | +3.2% | +11.5% |
| All | +21.6% | +18.4% | +3.2% | +11.5% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling